Luxbright AB (publ) (STO:LXB)
Sweden
· Delayed Price · Currency is SEK 0.7540
+0.0100 (1.34%)
May 23, 2025, 2:01 PM CET
Luxbright AB Revenue
In the year 2024, Luxbright AB had annual revenue of 12.03M SEK with 1,307.68% growth. Luxbright AB had revenue of 7.36M in the half year ending December 31, 2024, with 1,510.78% growth.
Revenue
12.03M
Revenue Growth
+1,307.68%
P/S Ratio
7.06
Revenue / Employee
1.20M
Employees
10
Market Cap
84.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.03M | 11.18M | 1,307.68% |
| Dec 31, 2023 | 854.70K | 43.00K | 5.30% |
| Dec 31, 2022 | 811.70K | 82.70K | 11.34% |
| Dec 31, 2021 | 729.00K | -636.00K | -46.59% |
| Dec 31, 2020 | 1.37M | -812.96K | -37.33% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |